The markers that can be utilised to identify cancer at an early stage are genomic biomarkers. A genomic test result-based biomarker is one called a Genomic Biomarker. It can be used to assess the efficacy of disease therapies, predict the risk of disease in healthy individuals, or determine whether a person has inherited an aberrant gene that raises their risk of developing cancer.
Tests for genetic alterations in DNA, proteins, or metabolites are performed using Genomic Biomarker. The investigation of a person's genome and proteome is included in genetic testing, also known as genomic testing. By examining how a person's genes react to specific medications, the technique aids in identifying gene changes that may raise the risk of developing cancer, directing treatment choices, and gauging therapeutic response.
Comments
0 comment